Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4.
about
A TLR5 agonist inhibits acute renal ischemic failureThe Role of Toll-Like Receptor 4 in Infectious and Noninfectious InflammationAntimicrobial Peptides in Human SepsisToll-like receptor activation: from renal inflammation to fibrosisHeparan Sulfate Proteoglycan Metabolism and the Fate of Grafted TissuesEpilepsy and innate immune system: A possible immunogenic predisposition and related therapeutic implicationsPattern-recognition receptors and gastric cancerEffect of TACI signaling on humoral immunity and autoimmune diseasesBiological interplay between proteoglycans and their innate immune receptors in inflammationRadiation as immunomodulator: implications for dendritic cell-based immunotherapyImmune-Mediated Inflammation May Contribute to the Pathogenesis of Cardiovascular Disease in Mucopolysaccharidosis Type IDanger Signals and Graft-versus-host Disease: Current Understanding and Future PerspectivesInnate immune pattern recognition: a cell biological perspectiveEarly neurodegeneration progresses independently of microglial activation by heparan sulfate in the brain of mucopolysaccharidosis IIIB miceSuppression of PLCbeta2 by endotoxin plays a role in the adenosine A(2A) receptor-mediated switch of macrophages from an inflammatory to an angiogenic phenotypeHow dying cells alert the immune system to dangerSterile inflammation: sensing and reacting to damageViperid Envenomation Wound Exudate Contributes to Increased Vascular Permeability via a DAMPs/TLR-4 Mediated Pathway.Gliomas induce and exploit microglial MT1-MMP expression for tumor expansionThe effect of neonatal gene therapy on skeletal manifestations in mucopolysaccharidosis VII dogs after a decade.Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejectionThe identity of innate immune activators in organ transplantation: origins from within or exterior to the host?From secretome analysis to immunology: chitosan induces major alterations in the activation of dendritic cells via a TLR4-dependent mechanism.The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury.Hemorrhagic shock augments lung endothelial cell activation: role of temporal alterations of TLR4 and TLR2.Proposed protective mechanism of the pancreas in the rat.TLR Cross-Talk Mechanism of Hemorrhagic Shock-Primed Pulmonary Neutrophil Infiltration.Effects of TLR agonists on the hypoxia-regulated transcription factor HIF-1alpha and dendritic cell maturation under normoxic conditionsExpression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis.Association of TLR4-T399I polymorphism with chronic obstructive pulmonary disease in smokers.Genetic deletion of toll-like receptor 4 on platelets attenuates experimental pulmonary hypertension.Upregulation of elastase activity in aorta in mucopolysaccharidosis I and VII dogs may be due to increased cytokine expression.The innate immune system in allograft rejection and tolerance.Mechanisms underlying blockade of allograft acceptance by TLR ligandsVersatile role of heparanase in inflammationNew insights into the functions of B cellsDAMPening inflammation by modulating TLR signalling.Association of Toll-like receptor signaling and reactive oxygen species: a potential therapeutic target for posttrauma acute lung injury.TLR4 dependent heparan sulphate-induced pancreatic inflammatory response is IRF3-mediatedTLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury.
P2860
Q24635867-4B90797E-313A-4319-AB15-EBA80E1A21E2Q26747005-DB2F85C3-D0B5-4823-AC63-65ED022C75DBQ26782811-5F0EB216-18DD-4218-A3DB-7CDE9D0E4879Q26796639-A3EA859D-7252-4D61-BEF7-7BE598646829Q26797410-1BE6B4EF-A002-4770-966F-8F0FD4733821Q26799604-AEABFE29-0C5D-4DCE-8C63-1043FE4D0CAFQ26991941-BD772066-118E-4800-940F-C2B2CAD16F02Q26995571-F57EC2E9-2D0C-49C1-ADE0-08D50B579CA8Q27005610-3B97DD73-AE0F-414F-8E6A-E809EF388874Q27025756-0E5A8A9F-1C8A-4AA8-B156-C8388B6E649BQ27318642-7D0CF3A1-20AC-4C83-92AB-8F3094728482Q28075204-128D0BBB-064A-4AF5-8749-D905677B7200Q28255348-1A9063F4-94EF-4645-B995-D992CEE451E7Q28472880-B6905063-A657-4CCA-83CF-85F2B71CE914Q28507352-8AB7030A-7386-4096-BE11-2740C5A38922Q29615501-C833BF52-2A7E-4B35-BDBC-40E361CD12E4Q29620014-E34CCCD1-0C93-468B-8BCA-D6B48145BF72Q30275356-9F1DA6D4-199D-42CB-8F52-52B95676CC3CQ30489174-AF6DBBCB-868E-423B-AA04-71605135D3A3Q30540876-23FED19A-8E08-4D2A-886E-EC3C0C8B3876Q33187036-5CA98CE0-B6B0-41DB-9BE1-D8C31C2CAD63Q33285697-56D09E96-1DF8-4E59-80F7-283DF7161447Q33417192-34C1402E-9917-43B0-A3E5-D16079B6B331Q33455868-E2EA13D2-E39A-467A-B95E-BADB03D9B547Q33579223-38FFAE01-334E-4F00-9E07-96F17921D83AQ33581229-E6FD3C60-AAC1-43D1-8173-444E223B628DQ33584615-E2A540BD-27DC-44FE-B214-0353CB1FBBFAQ33601510-0CEF3AFD-4080-4B88-851E-D39D32CE3716Q33614747-96CE17AE-EC6A-43C5-8741-76CA53DE99A2Q33654424-4285CD83-56DB-4F49-B1E6-30B43630F1CBQ33698036-0F455F65-1DD7-49E3-B310-0008FA41F5F3Q33729335-75041D25-2FAE-474E-BBB1-5E21757EAC0AQ33732470-EA46FF72-4900-4685-8D06-F0666154270CQ33732481-0E9304AC-3FFB-43D6-9970-D6D9E8F8E502Q33770777-A9355AC4-C5B2-4700-A5A8-39C021657A3FQ33936014-735136BE-E2D3-40C3-AF86-6B03B5973251Q34035570-4EFFC443-FE02-498C-98D5-0C4684DA28A8Q34035581-DE44CF07-E1AA-42F0-8915-365E6FF5AB4AQ34107852-57B1EB46-D1DF-4A98-8BD2-8956A928501CQ34124196-7E1F92FF-B687-41B0-8658-A82AF578CC7F
P2860
Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Receptor-mediated monitoring o ...... lfate by Toll-like receptor 4.
@en
type
label
Receptor-mediated monitoring o ...... lfate by Toll-like receptor 4.
@en
prefLabel
Receptor-mediated monitoring o ...... lfate by Toll-like receptor 4.
@en
P2093
P1476
Receptor-mediated monitoring o ...... lfate by Toll-like receptor 4.
@en
P2093
Gregory J Brunn
Jeffrey L Platt
Yuzo Kodaira
P304
P356
10.4049/JIMMUNOL.168.10.5233
P407
P577
2002-05-01T00:00:00Z